These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 27486979)
1. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979 [TBL] [Abstract][Full Text] [Related]
2. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors. Campa D; Capurso G; Pastore M; Talar-Wojnarowska R; Milanetto AC; Landoni L; Maiello E; Lawlor RT; Malecka-Panas E; Funel N; Gazouli M; De Bonis A; Klüter H; Rinzivillo M; Delle Fave G; Hackert T; Landi S; Bugert P; Bambi F; Archibugi L; Scarpa A; Katzke V; Dervenis C; Liço V; Furlanello S; Strobel O; Tavano F; Basso D; Kaaks R; Pasquali C; Gentiluomo M; Rizzato C; Canzian F Sci Rep; 2016 Dec; 6():39565. PubMed ID: 28008994 [TBL] [Abstract][Full Text] [Related]
3. Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations. Zhang H; Mao JS; Hu WF Med Sci Monit; 2019 Feb; 25():1307-1313. PubMed ID: 30774116 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Corradi C; Gentiluomo M; Gajdán L; Cavestro GM; Kreivenaite E; Di Franco G; Sperti C; Giaccherini M; Petrone MC; Tavano F; Gioffreda D; Morelli L; Soucek P; Andriulli A; Izbicki JR; Napoli N; Małecka-Panas E; Hegyi P; Neoptolemos JP; Landi S; Vashist Y; Pasquali C; Lu Y; Cervena K; Theodoropoulos GE; Moz S; Capurso G; Strobel O; Carrara S; Hackert T; Hlavac V; Archibugi L; Oliverius M; Vanella G; Vodicka P; Arcidiacono PG; Pezzilli R; Milanetto AC; Lawlor RT; Ivanauskas A; Szentesi A; Kupcinskas J; Testoni SGG; Lovecek M; Nentwich M; Gazouli M; Luchini C; Zuppardo RA; Darvasi E; Brenner H; Gheorghe C; Jamroziak K; Canzian F; Campa D Int J Cancer; 2021 Jun; 148(11):2779-2788. PubMed ID: 33534179 [TBL] [Abstract][Full Text] [Related]
6. Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility. Wang X; Li W; Ma L; Gao J; Liu J; Ping F; Nie M Acta Diabetol; 2015 Oct; 52(5):951-8. PubMed ID: 25990668 [TBL] [Abstract][Full Text] [Related]
8. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population. Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142 [TBL] [Abstract][Full Text] [Related]
9. CDC123/CAMK1D gene rs12779790 polymorphism and rs10811661 polymorphism upstream of the CDKN2A/2B gene in women with gestational diabetes. Tarnowski M; Malinowski D; Safranow K; Dziedziejko V; Pawlik A J Perinatol; 2017 Apr; 37(4):345-348. PubMed ID: 28079868 [TBL] [Abstract][Full Text] [Related]
10. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk. Giaccherini M; Farinella R; Gentiluomo M; Mohelnikova-Duchonova B; Kauffmann EF; Palmeri M; Uzunoglu F; Soucek P; Petrauskas D; Cavestro GM; Zykus R; Carrara S; Pezzilli R; Puzzono M; Szentesi A; Neoptolemos J; Archibugi L; Palmieri O; Milanetto AC; Capurso G; van Eijck CHJ; Stocker H; Lawlor RT; Vodicka P; Lovecek M; Izbicki JR; Perri F; Kupcinskaite-Noreikiene R; Götz M; Kupcinskas J; Hussein T; Hegyi P; Busch OR; Hackert T; Mambrini A; Brenner H; Lucchesi M; Basso D; Tavano F; Schöttker B; Vanella G; Bunduc S; Petrányi Á; Landi S; Morelli L; Canzian F; Campa D Int J Cancer; 2023 Jul; 153(2):373-379. PubMed ID: 36451333 [TBL] [Abstract][Full Text] [Related]
11. Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population. Lin X; Yan C; Gao Y; Du J; Zhu X; Yu F; Huang T; Dai J; Ma H; Jiang Y; Yin R; Hu Z; Jin G; Xu L; Shen H Cancer Sci; 2017 Feb; 108(2):250-255. PubMed ID: 27960044 [TBL] [Abstract][Full Text] [Related]
12. The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer. Kimura H; Klein AP; Hruban RH; Roberts NJ Pancreas; 2021 Sep; 50(8):1123-1130. PubMed ID: 34714275 [TBL] [Abstract][Full Text] [Related]
13. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423 [TBL] [Abstract][Full Text] [Related]
14. A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer. ShahidSales S; Mehramiz M; Ghasemi F; Aledavood A; Shamsi M; Hassanian SM; Ghayour-Mobarhan M; Avan A J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28276595 [TBL] [Abstract][Full Text] [Related]
15. Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans. Lee HS; Lee SB; Kim BM; Hong M; Jung S; Hong J; Baek J; Han B; Oh SH; Kim KM; Park SH; Yang SK; Ye BD; Song K J Gastroenterol Hepatol; 2018 Apr; 33(4):887-893. PubMed ID: 29063720 [TBL] [Abstract][Full Text] [Related]
16. Predictive performance of a genetic risk score using 11 susceptibility alleles for the incidence of Type 2 diabetes in a general Japanese population: a nested case-control study. Goto A; Noda M; Goto M; Yasuda K; Mizoue T; Yamaji T; Sawada N; Iwasaki M; Inoue M; Tsugane S; Diabet Med; 2018 May; 35(5):602-611. PubMed ID: 29444352 [TBL] [Abstract][Full Text] [Related]
17. Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population. Gutierrez-Camino A; Martin-Guerrero I; Garcia de Andoin N; Sastre A; Carbone Bañeres A; Astigarraga I; Navajas A; Garcia-Orad A PLoS One; 2017; 12(5):e0177421. PubMed ID: 28481918 [TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes. Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370 [TBL] [Abstract][Full Text] [Related]
19. Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association. Noury AE; Azmy O; Alsharnoubi J; Salama S; Okasha A; Gouda W BMC Res Notes; 2018 Mar; 11(1):181. PubMed ID: 29544538 [TBL] [Abstract][Full Text] [Related]
20. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan. Kuruma S; Egawa N; Kurata M; Honda G; Kamisawa T; Ueda J; Ishii H; Ueno M; Nakao H; Mori M; Matsuo K; Hosono S; Ohkawa S; Wakai K; Nakamura K; Tamakoshi A; Nojima M; Takahashi M; Shimada K; Nishiyama T; Kikuchi S; Lin Y World J Gastroenterol; 2014 Dec; 20(46):17456-62. PubMed ID: 25516658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]